API
< Back to all clusters
[CRIME] · United States · 2 sources

started · updated

Cyclorphine synthetic opioid identified as emerging drug threat in US

Cyclorphine, a potent synthetic opioid belonging to the orfina class, has been identified as an emerging drug threat in the United States. The substance has been linked to at least 122 deaths in the US since July 2025.

In response to its emergence, the US Drug Enforcement Administration designated cyclorphine as a temporary Schedule I controlled substance in August, making it illegal. Experts note that while the drug is highly potent, its presence remains more sporadic compared to fentanyl. Researchers at the University of North Carolina at Chapel Hill first detected the substance in the US in August 2024, though similar compounds were observed in Europe as early as 2019.

Experts suggest the rise of cyclorphine is a consequence of international efforts to ban fentanyl analogues, prompting illicit markets to develop alternative substances that produce similar effects. The drug has been detected in approximately 25 states, including Illinois and Tennessee, where it is often found in powder form mixed with fentanyl.

Entities

Office of National Drug Control Policy · United States Drug Enforcement Administration · University of North Carolina at Chapel Hill